Search
Search Results
-
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
BackgroundPaliperidone is a second-generation antipsychotic agent that is effective in the treatment of schizophrenia and schizoaffective disorder as...
-
Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis
Is paliperidone palmitate (PP) a useful treatment option for adults with acute symptoms of schizophrenia? We conducted a systematic review and a...
-
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
BackgroundTo analyze the economic benefits of paliperidone palmitate in the treatment of schizophrenia.
MethodsWe collected 546 patients who met the...
-
Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
Background and ObjectivesIdentifying key factors for a successful transition from once-monthly paliperidone palmitate (PP1M) to three-monthly...